Morgan Stanley Maintains Underweight on Virtus Inv, Raises Price Target to $119

Benzinga Newsdesk www.benzinga.com Positive 82.2%

Neg 0% Neu 0% Pos 82.2%

Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and raises the price target from $112 to $119.